Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03626324 · ClinicalTrials.gov registry record · NA
Connected Catheter (C2P) Study for Bladder Management
A NA study, sponsored by Spinal Singularity.
- Completed
- Registry status
- NA
- Development phase
- 27
- Enrollment target
NCT03626324 is a NA study that has completed, run by Spinal Singularity. The registered enrollment target is 27 participants.
The verdict
NCT03626324, a NA study, has completed, sponsored by Spinal Singularity.
- COMPLETED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the safety and essential performance of the C2P System in males with neurogenic lower urinary tract dysfunction (NLUTD), both in an acute clinical setting and an extended period of home use.
Interventions
- DEVICE C2P
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2018-07-25 |
| Est. Completion | 2019-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03626324
The ClinicalTrials.gov registry entry for NCT03626324 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Spinal Singularity, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which C2P is the first listed.
NCT03626324 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03626324 about?
NCT03626324 is a clinical study titled "Connected Catheter (C2P) Study for Bladder Management". The objective of this study is to evaluate the safety and essential performance of the C2P System in males with neurogenic lower urinary tract dysfunction (NLUTD), both in an acute clinical setting and an extended period of home use.
What is the current status of trial NCT03626324?
This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2018-07-25. Estimated completion is 2019-01-31.
What interventions are being tested in trial NCT03626324?
The interventions under investigation include: C2P (DEVICE).
Who is sponsoring clinical trial NCT03626324?
This trial is sponsored by Spinal Singularity, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.